
Consumer Health in Lithuania
Description
Consumer Health in Lithuania
Consumer health sales in Lithuania are resettling in 2024 following fluctuations during and following the COVID-19 pandemic. Overall, sales are generally fairly stagnant with declines in some segments – largely due to a stabilised consumer base following a temporary boost by migration from Ukraine and other countries.
Euromonitor International's Consumer Health in Lithuania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
81 Pages
- Consumer Health in Lithuania
- Euromonitor International
- October 2024
- List Of Contents And Tables
- CONSUMER HEALTH IN LITHUANIA
- EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 2 Life Expectancy at Birth 2019-2024
- MARKET DATA
- Table 3 Sales of Consumer Health by Category: Value 2019-2024
- Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 7 Penetration of Private Label by Category: % Value 2019-2024
- Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
- ANALGESICS IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Robust rises in 2024 although mainly due to price hikes
- Marketing and promotions attract consumers as category remains led by international players
- Solpadine suffers supply issues
- PROSPECTS AND OPPORTUNITIES
- Category growth looks set to be solid
- Ibuprofen will maintain stronghold as overall category lacks innovation
- Naproxen holds potential for expansion, while modern grocery retailers expand
- CATEGORY DATA
- Table 12 Sales of Analgesics by Category: Value 2019-2024
- Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
- Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
- Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
- Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
- Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- 2024 sees little change
- Low flu incidence undermines overall demand
- Non-drowsy Opexa marches onwards
- PROSPECTS AND OPPORTUNITIES
- Moderate growth predicated for forecast period
- Lack of innovation to persist, while decongest sprays gather further ground
- Climate change continues to push up incidence of allergies
- CATEGORY DATA
- Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
- Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
- Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
- Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
- Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
- Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
- DIGESTIVE REMEDIES IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Value growth driven by rising prices
- A Menarini Industrie Farmaceutiche Riunite maintains overall leadership
- Dosages increase as consumers seek sure results though volume sales remain limited by lack of significant innovation
- PROSPECTS AND OPPORTUNITIES
- Low but stable sales across category
- Widespread reflux will support antacids, and ageing population will drive value growth
- Limited local presence in competitive landscape
- CATEGORY DATA
- Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
- Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
- Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
- Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
- Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
- Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
- DERMATOLOGICALS IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Convincing performance from dermatologicals in 2024
- Female-oriented products and topical antifungals gain ground
- Multinationals continue to lead, leaving little space for local players
- PROSPECTS AND OPPORTUNITIES
- Little change anticipated for dermatologicals
- Cold sore treatments will continue to expand but vaginal antifungals has reached its peak
- Out-of-home habits to support topical antiseptics while hair loss sales will benefit from innovation
- CATEGORY DATA
- Table 30 Sales of Dermatologicals by Category: Value 2019-2024
- Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
- Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
- Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
- Table 34 Forecast Sales of Dermatologicals by Category: Value 2024-2029
- Table 35 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
- WOUND CARE IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Early summer bodes well for wound care
- Sticking plasters/adhesive still largest subcategory
- Private label expands within landscape led by multinationals.
- PROSPECTS AND OPPORTUNITIES
- Volume sales likely to stagnate
- Private label will continue to steal share
- Niche and premium products may rise slightly
- CATEGORY DATA
- Table 36 Sales of Wound Care by Category: Value 2019-2024
- Table 37 Sales of Wound Care by Category: % Value Growth 2019-2024
- Table 38 NBO Company Shares of Wound Care: % Value 2020-2024
- Table 39 LBN Brand Shares of Wound Care: % Value 2021-2024
- Table 40 Forecast Sales of Wound Care by Category: Value 2024-2029
- Table 41 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029
- VITAMINS IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Volume growth declines in 2024
- Vitamin B rises as D falls
- Valentis maintains leadership label remains strong
- PROSPECTS AND OPPORTUNITIES
- Moderate forecast period facing vitamins in Lithuania
- Multivitamins will continue to be popular
- Single vitamins face varied fortunes while multivitamins will see greater specificity
- CATEGORY DATA
- Table 42 Sales of Vitamins by Category: Value 2019-2024
- Table 43 Sales of Vitamins by Category: % Value Growth 2019-2024
- Table 44 Sales of Multivitamins by Positioning: % Value 2019-2024
- Table 45 NBO Company Shares of Vitamins: % Value 2020-2024
- Table 46 LBN Brand Shares of Vitamins: % Value 2021-2024
- Table 47 Forecast Sales of Vitamins by Category: Value 2024-2029
- Table 48 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029
- DIETARY SUPPLEMENTS IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Stable growth for dietary supplements
- Fish oils goes from strength to strength and eye health sees further expansion
- Direct selling remains relevant in a fragmented landscape
- PROSPECTS AND OPPORTUNITIES
- Only low growth predicted for dietary supplements
- Private label will benefit from currently small presence within category
- Combination products to see rising demand, while joint health holds potential
- CATEGORY DATA
- Table 49 Sales of Dietary Supplements by Category: Value 2019-2024
- Table 50 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
- Table 51 Sales of Dietary Supplements by Positioning: % Value 2019-2024
- Table 52 NBO Company Shares of Dietary Supplements: % Value 2020-2024
- Table 53 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
- Table 54 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
- Table 55 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029
- WEIGHT MANAGEMENT AND WELLBEING IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Decline for weight loss supplements continues into 2024
- Direct selling offers sports nutrition to boost sales
- Ozempic usage grows while slimming teas gains ground
- PROSPECTS AND OPPORTUNITIES
- Decline for weight loss supplements shows no sign of reversal
- Direct selling to remain primary distribution channel
- Slimming teas to see positive but low volume growth as consumers shift to healthier options
- CATEGORY DATA
- Table 56 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
- Table 57 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
- Table 58 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
- Table 59 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
- Table 60 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
- Table 61 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029
- SPORTS NUTRITION IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Sports nutrition makes further gains in 2024
- Sports protein-based products keep on rising
- E-commerce is major channel for sports nutrition sales
- PROSPECTS AND OPPORTUNITIES
- Bright future anticipated for sports nutrition
- Local players will maintain market presence amid expanding retail presence
- Protein bars contain high potential, with e-commerce further strengthening its commanding lead in distribution
- CATEGORY DATA
- Table 62 Sales of Sports Nutrition by Category: Value 2019-2024
- Table 63 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
- Table 64 NBO Company Shares of Sports Nutrition: % Value 2020-2024
- Table 65 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
- Table 66 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
- Table 67 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029
- HERBAL/TRADITIONAL PRODUCTS IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Moderate growth posted in 2024
- Eucarbon Herbal leads herbal digestive remedies brands, while Sinupret maintains overall category lead
- Local player Valentis gains value share in 2024
- PROSPECTS AND OPPORTUNITIES
- Low growth ahead for herbal/traditional products in Lithuania
- Sleep aids likely to see volume rises while Valentis benefits from strong reputation for paediatric solutions
- Haemorrhoid treatments to maintain presence in herbal dermatologicals, and environmental focus could expand consumer base
- CATEGORY DATA
- Table 68 Sales of Herbal/Traditional Products: Value 2019-2024
- Table 69 Sales of Herbal/Traditional Products: % Value Growth 2019-2024
- Table 70 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
- Table 71 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
- Table 72 Forecast Sales of Herbal/Traditional Products: Value 2024-2029
- Table 73 Forecast Sales of Herbal/Traditional Products: % Value Growth 2024-2029
- PAEDIATRIC CONSUMER HEALTH IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Post-pandemic surge settles down
- Ibuprofen still preferred product, with fish oil also popular
- Continued shift towards products with a natural positioning
- PROSPECTS AND OPPORTUNITIES
- Moderate growth predicted for overall category
- Vitamins and dietary supplements set to do well
- No sign of new challengers
- CATEGORY DATA
- Table 74 Sales of Paediatric Consumer Health by Category: Value 2019-2024
- Table 75 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
- Table 76 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
- Table 77 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.